HR 1839
107th Congress
House
Health
Coinsurance
Employee health benefits
Finance and Financial Sector
Health insurance
Hospital care
Immunosuppressive drugs
Insurance premiums
Kidney diseases
Labor and Employment
Medicare
Social Welfare
Transplantation of organs, tissues, etc.
Immunosuppressive Drug Coverage Act of 2001
Introduced: May 15, 2001
See on congress.gov
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 16, 2001
Referred to the Subcommittee on Employer-Employee Relations.
May 22, 2001
Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.
May 18, 2001
Referred to the Subcommittee on Health.
May 15, 2001
Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 15, 2001
Introduced in House
Plain-English summary
Immunosuppressive Drug Coverage Act of 2001 - Amends title II (Old Age, Survivors and Disability Insurance) (OASDI) of the Social Security Act to: (1) continue entitlement to prescription drugs used in immunosuppressive therapy furnished to an individual who receives a kidney transplant for which payment is made under Medicare; and (2) extend Medicare secondary payer requirements for end stage renal disease beneficiaries.
Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code to set forth requirements for group health plans to provide coverage of immunosuppressive drugs.
What's happening now
Referred to the Subcommittee on Employer-Employee Relations.